Insights on Discovery
-
mRNA LNPs Drive Safe, Effective Repeat Dosing In Disease Models
6/19/2026
Well-designed lipid nanoparticles enable safe, efficient delivery. OVA-based models show how formulation choices shape efficacy, safety, and anti-tumor outcomes in melanoma research.
-
CRISPR Reagents Enable High Efficiencies Of Editing And HDR In iPSCs
6/15/2026
Achieving consistent Homology Directed Repair (HDR) in iPSCs requires optimized CRISPR design and workflows. See how advanced reagents and targeted enhancement strategies improve insertion efficiency.
-
CAR Detection Reagents - Applications For Flow Cytometry
6/11/2026
Precise detection of CAR T cells supports reliable analysis and imaging across workflows. See how flexible reagent strategies reduce background, improve specificity, and enable deeper insight.
-
Closing The QC Gap For mAbs: Rapid Answers Without Compromising
6/9/2026
Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.
-
Designing RNase H1 "Gapmer" Antisense Oligonucleotides
6/9/2026
Effective RNA-targeting oligonucleotide design hinges on balancing affinity, stability, and selectivity. Explore how chemical modifications, sequence choices, and delivery approaches influence potency.
-
T Cells In Immunotherapies: The Key Progress Underway
6/1/2026
CAR-T therapies now make up 73% of active pipeline programs, yet solid tumors remain largely out of reach. Where is T cell immunotherapy headed next, and what does it mean for your pipeline strategy?
-
Materials Matter: Reframing Raw Material Strategy In Cell And Gene Therapy Development
5/1/2026
Scaling iPSC-based therapies from lab to CGMP manufacturing demands tightly controlled cryopreservation, risk-based QC, and strategic automation to preserve cell viability, consistency, and regulatory readiness.
-
Sensitive Viral Safety Testing For Adventitious Virus Detection
4/20/2026
Discover a modern approach to adventitious virus detection that shows how targeted sequencing can achieve sensitive, comprehensive viral safety testing aligned with ICH MAP, RAP, and HAP expectations.
-
Direct Cell Lysis Enables Rapid And Robust Vector Copy Number (VCN) Quantification Using QIAcuity Digital PCR
4/20/2026
Explore a faster approach to vector copy number measurement that replaces DNA extraction with direct cell lysis and digital PCR, delivering accurate, reproducible results across fresh and frozen samples.
-
Enhanced Lentiviral Vector Characterization Using Digital PCR
4/20/2026
Digital PCR offers a precise, scalable approach to lentiviral vector characterization, enabling reliable genome titer, vector copy number, and RCL detection while reducing variability.